Drug General Information
Drug ID
D06SPO
Former ID
DNC013971
Drug Name
3,5-dichlorosalicylic acid
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529899]
Structure
Download
2D MOL

3D MOL

Formula
C7H4Cl2O3
Canonical SMILES
C1=C(C=C(C(=C1Cl)O)C(=O)O)Cl
InChI
1S/C7H4Cl2O3/c8-3-1-4(7(11)12)6(10)5(9)2-3/h1-2,10H,(H,11,12)
InChIKey
CNJGWCQEGROXEE-UHFFFAOYSA-N
PubChem Compound ID
Target and Pathway
Target(s) Aldose reductase Target Info Inhibitor [529899]
Alcohol dehydrogenase Target Info Inhibitor [529899]
BioCyc Pathway Methylglyoxal degradation III
Acetone degradation I (to methylglyoxal)PWY66-401:Superpathway of tryptophan utilization
Tryptophan degradation via tryptamine
KEGG Pathway Pentose and glucuronate interconversions
Fructose and mannose metabolism
Galactose metabolism
Glycerolipid metabolism
Metabolic pathwayshsa00010:Glycolysis / Gluconeogenesis
Metabolic pathways
Biosynthesis of antibiotics
Degradation of aromatic compounds
NetPath Pathway IL1 Signaling Pathway
TGF_beta_Receptor Signaling Pathway
PathWhiz Pathway Fructose and Mannose Degradation
Pyruvate Metabolism
Pterine Biosynthesis
Glycerolipid Metabolism
Galactose Metabolism
WikiPathways Metapathway biotransformation
Polyol Pathway
Metabolism of steroid hormones and vitamin DWP702:Metapathway biotransformation
Benzo(a)pyrene metabolism
References
Ref 529899Bioorg Med Chem. 2009 Feb 1;17(3):1244-50. Epub 2008 Dec 24.Correlation of binding constants and molecular modelling of inhibitors in the active sites of aldose reductase and aldehyde reductase.
Ref 529899Bioorg Med Chem. 2009 Feb 1;17(3):1244-50. Epub 2008 Dec 24.Correlation of binding constants and molecular modelling of inhibitors in the active sites of aldose reductase and aldehyde reductase.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.